{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:59:39Z","timestamp":1790078379576,"version":"4.0.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Chronic pulmonary infections caused by multidrug-resistant (MDR) bacteria are a growing global health problem, and the declining effectiveness of conventional antibiotics increases the need for alternative antimicrobial strategies. Unlike broad-spectrum antibiotics, bacteriophages are highly specific, and their use therefore offers not only antibacterial activity but also the possibility of reshaping the airway microbial ecosystem in a targeted manner. In this review, we reframe phage therapy as a precision microbiome-modulating strategy for chronic pulmonary infections. We first review precision pathogen identification and phage-host matching, then discuss formulation engineering for pulmonary delivery, and then examine the interactions between phages and host immune barriers. We further analyze how phage therapy may selectively deplete MDR pathogens while sparing the commensal microbiota and how it may remodel the airway microbial ecosystem, and we critically evaluate the clinical evidence, distinguishing preclinical data, case-based evidence, observational studies, and controlled trials. By integrating these dimensions, we identify the main scientific and technical challenges and evidence gaps that currently limit clinical implementation, and we discuss strategies that could support the development of safe, effective, and clinically applicable phage-based therapies for chronic pulmonary infections.<\/jats:p>","DOI":"10.3389\/fcimb.2026.1968526","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:00:04Z","timestamp":1790074804000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Phage therapy for multidrug-resistant pulmonary infections: bridging precision matching, lung delivery, host immunity, and clinical translation"],"prefix":"10.3389","volume":"16","author":[{"given":"Ran","family":"Xiao","sequence":"first","affiliation":[{"name":"Central Laboratory, Department of Clinical Laboratory, Guizhou Aerospace Hospital","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hao","sequence":"additional","affiliation":[{"name":"Central Laboratory, Department of Clinical Laboratory, Guizhou Aerospace Hospital","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Gong","sequence":"additional","affiliation":[{"name":"Central Laboratory, Department of Clinical Laboratory, Guizhou Aerospace Hospital","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjun","family":"She","sequence":"additional","affiliation":[{"name":"Central Laboratory, Department of Clinical Laboratory, Guizhou Aerospace Hospital","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Ma","sequence":"additional","affiliation":[{"name":"Central Laboratory, Department of Clinical Laboratory, Guizhou Aerospace Hospital","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Lin","sequence":"additional","affiliation":[{"name":"Central Laboratory, Department of Clinical Laboratory, Guizhou Aerospace Hospital","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubing","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Medical Center Hamburg-Eppendorf","place":["Hamburg, Germany"]},{"name":"Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg-Eppendorf","place":["Hamburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Jiang","sequence":"additional","affiliation":[{"name":"Central Laboratory, Department of Clinical Laboratory, Guizhou Aerospace Hospital","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1099\/acmi.0.001001.v3","article-title":"In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis","volume":"7","author":"Ali","year":"2025","journal-title":"Access Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5283526","DOI":"10.1155\/bmri\/5283526","article-title":"Incidence and antibiotic susceptibility of Gram-negative bacteria associated with chest infections in intensive care unit patients from a selected hospital in the Kingdom of Saudi Arabia","volume":"2025","author":"Almouwlid","year":"2025","journal-title":"BioMed. Res. Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/14787210.2026.2632669","article-title":"Phage therapy: innovations, challenges, and future directions in combating superbugs and antibiotic resistance","volume":"24","author":"Bhale","year":"2026","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/bit.28581","article-title":"The therapeutic effect of engineered phage, derived protein and enzymes against superbug bacteria","volume":"121","author":"Boroujeni","year":"2024","journal-title":"Biotechnol. Bioeng."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16070904","article-title":"A new Casjensviridae bacteriophage isolated from hospital sewage for inactivation of biofilms of carbapenem resistant Klebsiella pneumoniae clinical isolates","volume":"16","author":"Chakraborty","year":"2024","journal-title":"Pharmaceutics."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41591-025-03678-8","article-title":"Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis","volume":"31","author":"Chan","year":"2025","journal-title":"Nat. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/jamp.2021.0045","article-title":"Inhaled delivery of anti-Pseudomonal phages to tackle respiratory infections caused by superbugs","volume":"35","author":"Chan","year":"2022","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ph16101347","article-title":"The safety of bacteriophages in treatment of diseases caused by multidrug-resistant bacteria","volume":"16","author":"Chung","year":"2023","journal-title":"Pharm. (Basel)."},{"key":"B9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1089\/phage.2023.0034","article-title":"A case of persistent intra-abdominal Stenotrophomonas maltophilia infection despite bacteriophage therapy","volume":"5","author":"Cullen","year":"2024","journal-title":"Phage. (New. Rochelle)."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1397447","article-title":"Physiochemical characterization of a potential Klebsiella phage MKP-1 and analysis of its application in reducing biofilm formation","volume":"15","author":"Das","year":"2024","journal-title":"Front. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1014408","article-title":"Towards modeling phage therapy","volume":"22","author":"de Boer","year":"2026","journal-title":"PloS Comput. Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1111\/jcpt.13787","article-title":"Acinetobacter baumannii: pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecycline","volume":"47","author":"Dehbanipour","year":"2022","journal-title":"J. Clin. Pharm. Ther."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/v17111441","article-title":"Rational design of a potent two-phage cocktail against a contemporary Acinetobacter baumannii strain recovered from a burned patient at the Lausanne University Hospital","volume":"17","author":"de Villiers de la Noue","year":"2025","journal-title":"Viruses."},{"key":"B15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12941-025-00818-3","article-title":"The bacterial etiology and antimicrobial susceptibility of lower respiratory tract infections in Vietnam","volume":"24","author":"Dung","year":"2025","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/jambio\/lxaf131","article-title":"Bacteriophage-antibiotic synergy enhances therapeutic efficacy against multidrug-resistant Klebsiella pneumoniae infections","volume":"136","author":"El-Din","year":"2025","journal-title":"J. Appl. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17081077","article-title":"Latest advances in inhalable dry powder bacteriophage therapy for pulmonary infections","volume":"17","author":"Encinas-Basurto","year":"2025","journal-title":"Pharmaceutics."},{"key":"B18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12985-025-02885-6","article-title":"Isolation and characterization of phages \u03a6ZC2 and \u03a6ZC3 against carbapenem-resistant Acinetobacter baumannii, and efficacy of \u03a6ZC3 on A549 cells","volume":"22","author":"Essam","year":"2025","journal-title":"Virol. J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s13346-024-01662-2","article-title":"Nanoparticles in liposomes: a platform for increased antibiotic selectivity in multidrug resistant bacteria in respiratory tract infections","volume":"15","author":"Fakhoury","year":"2025","journal-title":"Drug Delivery Transl. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ajt.2025.11.008","article-title":"From resistance to response: bacteriophages in multidrug-resistant Mycobacterium abscessus after lung transplantation","volume":"26","author":"Ferreiro-Posse","year":"2026","journal-title":"Am. J. Transplant."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cells12162057","article-title":"Stability considerations for bacteriophages in liquid formulations designed for nebulization","volume":"12","author":"Flint","year":"2023","journal-title":"Cells."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/jam.15642","article-title":"Immunological and safety profile of bacteriophage therapy: a pre-clinical study","volume":"133","author":"Gangwar","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2025.110583","article-title":"Mini-review: insight of bacteriophage therapy in clinical practice","volume":"610","author":"Ghosh","year":"2025","journal-title":"Virology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12866-025-03851-6","article-title":"Potential of a phage cocktail in the treatment of multidrug-resistant Klebsiella pneumoniae pulmonary infection in mice","volume":"25","author":"Gou","year":"2025","journal-title":"BMC Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41598-022-26696-9","article-title":"Characterisation and sequencing of the novel phage Abp95, which is effective against multi-genotypes of carbapenem-resistant Acinetobacter baumannii","volume":"13","author":"Huang","year":"2023","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/v13091809","article-title":"Phage therapy for multi-drug resistant respiratory tract infections","volume":"13","author":"Iszatt","year":"2021","journal-title":"Viruses."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI187996","article-title":"Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches","volume":"135","author":"Kim","year":"2025","journal-title":"J. Clin. Invest."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02019-25","article-title":"A novel broad host range phage phiA85 displays a synergistic effect with antibiotics targeting carbapenem-resistant Klebsiella pneumoniae","volume":"13","author":"Li","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2026.108290","article-title":"Pairing antibiotics with phages: a new strategy to tackle biofilms of drug-resistant Acinetobacter baumannii-insights from in vitro and in vivo studies","volume":"213","author":"Moghadam","year":"2026","journal-title":"Microb. Pathog."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121616","article-title":"Isolation and characterization of lytic bacteriophages capable of infecting diverse multidrug-resistant strains of Pseudomonas aeruginosa: PaCCP1 and PaCCP2","volume":"17","author":"Parra","year":"2024","journal-title":"Pharm. (Basel)."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125602","article-title":"Powder aerosol formulation of Pseudomonas aeruginosa bacteriophage for pulmonary delivery","volume":"676","author":"Pathak","year":"2025","journal-title":"Int. J. Pharm."},{"key":"B32","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1021\/acs.chemrev.4c00681","article-title":"Engineering phages to fight multidrug-resistant bacteria","volume":"125","author":"Peng","year":"2025","journal-title":"Chem. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.2147\/IDR.S547655","article-title":"Efficacy of phage cocktails against biofilms formed by antibiotic-resistant bacteria","volume":"18","author":"Poniatovskyi","year":"2025","journal-title":"Infect. Drug Resist."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01602-22","article-title":"Engineered bacteriophages containing anti-CRISPR suppress infection of antibiotic-resistant P. aeruginosa","volume":"10","author":"Qin","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12866-023-02979-7","article-title":"Characterization of novel bacteriophage PSKP16 and its therapeutic potential against \u03b2-lactamase and biofilm producer strain of K2-hypervirulent Klebsiella pneumoniae pneumonia infection in mice model","volume":"23","author":"Rahimi","year":"2023","journal-title":"BMC Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"220068","DOI":"10.1183\/16000617.0068-2022","article-title":"The threat of multidrug-resistant\/extensively drug-resistant Gram-negative respiratory infections: another pandemic","volume":"31","author":"Reynolds","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00171-24","article-title":"Metapopulation model of phage therapy of an acute Pseudomonas aeruginosa lung infection","volume":"9","author":"Rodriguez-Gonzalez","year":"2024","journal-title":"mSystems."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1177\/20499361241307841","article-title":"Phage therapy in the management of respiratory and pulmonary infections: a systematic review","volume":"12","author":"Sarkodie-Addo","year":"2025","journal-title":"Ther. Adv. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00203-026-04839-0","article-title":"Pseudomonas aeruginosa: associated pathogenesis, epidemiology, resistance mechanisms, host response and emerging treatment strategies","volume":"208","author":"Sawant","year":"2026","journal-title":"Arch. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"28992","DOI":"10.1038\/s41598-024-79924-9","article-title":"Phage cocktail amikacin combination as a potential therapy for bacteremia associated with carbapenemase producing colistin resistant Klebsiella pneumoniae","volume":"14","author":"Shein","year":"2024","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ph19050727","article-title":"Phage therapy in combating multidrug-resistant Gram-negative pathogens: a scoping review","volume":"19","author":"Sukri","year":"2026","journal-title":"Pharm. (Basel)."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01822-25","article-title":"Reprogramming resistance: phage-antibiotic synergy targets efflux systems in ESKAPEE pathogens","volume":"16","author":"Tarasenko","year":"2025","journal-title":"mBio."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2026.108789","article-title":"Mapping the clinical use of inhaled bacteriophages in respiratory infections caused by multidrug-resistant pathogens: a scoping review","volume":"256","author":"Terzi","year":"2026","journal-title":"Respir. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"240029","DOI":"10.1183\/16000617.0029-2024","article-title":"Phage therapy: breathing new tactics into lower respiratory tract infection treatments","volume":"33","author":"Vaezi","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12664-024-01712-0","article-title":"Bacterial resistance profile and its association with poor outcome among cirrhosis patients attending a tertiary care referral center in northern India","volume":"44","author":"Varghese","year":"2025","journal-title":"Indian J. Gastroenterol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/molecules31020324","article-title":"Bacteriophage therapy: overcoming antimicrobial resistance through advanced delivery methods","volume":"31","author":"Wacnik","year":"2026","journal-title":"Molecules."},{"key":"B47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/14728222.2026.2639679","article-title":"Lipopolysaccharide-targeting treatments for multidrug-resistant Pseudomonas aeruginosa","volume":"30","author":"Wang","year":"2026","journal-title":"Expert Opin. Ther. Targets"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107950","article-title":"Isolation, characterization, therapeutic potential and depolymerase identification of a lytic bacteriophage Kpp-9 against Klebsiella pneumoniae with capsule serotype K2","volume":"208","author":"Wang","year":"2025","journal-title":"Microb. Pathog."},{"key":"B49","doi-asserted-by":"publisher","first-page":"807","DOI":"10.12182\/20260560602","article-title":"Characteristics of the pathogenic bacteria isolated from the lower respiratory tract of the patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"57","author":"Wang","year":"2026","journal-title":"Sichuan. Da. Xue. Xue. Bao. Yi. Xue. Ban."},{"key":"B50","doi-asserted-by":"publisher","first-page":"33512","DOI":"10.1038\/s41598-025-17510-3","article-title":"A case report of bacteriophage therapy for the treatment of lung infection due to carbapenem-resistant Pseudomonas aeruginosa","volume":"15","author":"Yang","year":"2025","journal-title":"Sci. Rep."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2026.1879718","article-title":"Bacteriophage therapy beyond antibiotics: emerging innovations for infectious and non-infectious diseases","volume":"16","author":"Zhang","year":"2026","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2026.1851410","article-title":"Phage-antibiotic synergy attenuates Acinetobacter baumannii resistance in refractory pneumonia: a precision therapeutic case","volume":"16","author":"Zhang","year":"2026","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1968526\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:00:07Z","timestamp":1790074807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1968526\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":52,"alternative-id":["10.3389\/fcimb.2026.1968526"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1968526","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1968526"}}